<p>Disclosed are compounds that inhibit Lp-PLA2 activity, processes for their preparation, compositions containing them and their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.</p>
申请公布号
WO2012075917(A1)
申请公布日期
2012.06.14
申请号
WO2011CN83465
申请日期
2011.12.05
申请人
GLAXO GROUP LIMITED;WAN, ZEHONG;ZHANG, XIAOMIN;WANG, JIAN;PENG, CHENG;JIN, YUN;HU, YIMIN
